Nikolaj C. Torp

Odense, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 45 publications

Reply.

Reply.

Journal: Gastroenterology

Published: May 21, 2026

Editorial: Two Common Risks, One Greater Harm-Diabetes and Alcohol in Steatotic Liver Disease.

Editorial: Two Common Risks, One Greater Harm-Diabetes and Alcohol in Steatotic Liver Disease.

Journal: Alimentary pharmacology & therapeutics

Published: April 25, 2026

Role of spot urine analyses in patients with cirrhosis and ascites as the single first decompensation event.

Role of spot urine analyses in patients with cirrhosis and ascites as the single first decompensation event.

Journal: Annals of hepatology

Published: February 26, 2026

Role of spot urine analyses in patients with cirrhosis and ascites as the single first decompensation event.

Role of spot urine analyses in patients with cirrhosis and ascites as the single first decompensation event.

Journal: Annals of hepatology

Published: February 26, 2026

Fibrosis activity vs. disease stage: Complementary and independent predictors of outcomes in alcohol-related liver disease.

Fibrosis activity vs. disease stage: Complementary and independent predictors of outcomes in alcohol-related liver disease.

Journal: JHEP reports : innovation in hepatology

Published: October 17, 2025

Limited clinical utility of serum-based ELISA PEth compared with whole-blood LC-MS/MS PEth to quantify alcohol consumption.

Limited clinical utility of serum-based ELISA PEth compared with whole-blood LC-MS/MS PEth to quantify alcohol consumption.

Journal: Journal of hepatology

Published: October 07, 2025

Health-related quality of life, compliance and sustained adherence on a low-carbohydrate high-fat diet compared with a high-carbohydrate low-fat diet in people with type 2 diabetes.

Health-related quality of life, compliance and sustained adherence on a low-carbohydrate high-fat diet compared with a high-carbohydrate low-fat diet in people with type 2 diabetes.

Journal: The American journal of clinical nutrition

Published: October 03, 2025

Paired Liver Biopsies vs Noninvasive Tests as Surrogate Endpoints for Clinical Trials in Metabolic and Alcohol-Related Liver Disease and Alcohol-Related Liver Disease.

Paired Liver Biopsies vs Noninvasive Tests as Surrogate Endpoints for Clinical Trials in Metabolic and Alcohol-Related Liver Disease and Alcohol-Related Liver Disease.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: September 26, 2025

Editorial: Implementing Risk Assessment Tools for MetALD in Clinical Practice-Authors' Reply.

Editorial: Implementing Risk Assessment Tools for MetALD in Clinical Practice-Authors' Reply.

Journal: Alimentary pharmacology & therapeutics

Published: August 12, 2025

Limitations of MELD and MELD 3.0 for prognostication in patients with cirrhosis hospitalized with acute decompensation: an analysis of the ATTIRE trial.

Limitations of MELD and MELD 3.0 for prognostication in patients with cirrhosis hospitalized with acute decompensation: an analysis of the ATTIRE trial.

Journal: Annals of hepatology

Published: July 25, 2025

Prognostic Performance of Phosphatidylethanol With Noninvasive Liver Fibrosis Tests in Alcohol-Related Liver Disease.

Prognostic Performance of Phosphatidylethanol With Noninvasive Liver Fibrosis Tests in Alcohol-Related Liver Disease.

Journal: Gastroenterology

Published: July 07, 2025

PD-L1 and the risk of bacterial infection in patients with chronic liver diseases: An international multicohort study.

PD-L1 and the risk of bacterial infection in patients with chronic liver diseases: An international multicohort study.

Journal: JHEP reports : innovation in hepatology

Published: June 28, 2025

Showing 1-12 of 45

Last Updated: 09/26/2026